Skip to main content
main-content
Erschienen in: CME 12/2019

11.12.2019 | Atemwegsinfekte in der Hausarztpraxis | CME Fortbildung

Infektionen der oberen Atemwege

verfasst von: MPH Dr. med. Inga Petruschke, Prof. Dr. Mathias W. Pletz, Prof. Dr. Jutta Bleidorn

Erschienen in: CME | Ausgabe 12/2019

Einloggen, um Zugang zu erhalten

Zusammenfassung

Obwohl die Verordnungsrate von Antibiotika insgesamt zurückgegangen ist, werden immer noch zu viele Fluorchinolone und Cephalosporine im ambulanten Bereich verordnet. Die akute Rhinosinusitis ist überwiegend viral bedingt und bedarf keiner antibiotischen Behandlung. Zur symptomatischen Behandlung können Inhalationen, Nasenspülung sowie pflanzliche Wirkstoffe eingesetzt werden. Ein Antibiotikum (erste Wahl: Amoxicillin) ist nur bei Patienten mit starken Schmerzen und erhöhten Entzündungsparametern indiziert.Bei akuter Pharyngotonsillitis sollte ein Antibiotikum nur bei ausgewählten Patienten zum Einsatz kommen, Mittel der Wahl ist dann Penicillin V. Die akute Bronchitis ist zu 90% viral bedingt, eine Sputumverfärbung ist keine Indikation für ein Antibiotikum. Innerhalb der ersten sechs Wochen sollte eine symptomatische Therapie mit Inhalationen, Analgetika und Phytotherapeutika erfolgen. Der Einsatz der „verzögerten Verordnung“ hilft, unnötige Antibiotikaeinnahmen zu reduzieren.
Literatur
1.
Zurück zum Zitat Bätzing-Feigenbaum, J., et al., Outpatient antibiotic prescription: a population-based study on regional age-related use of cephalosporins and fluoroquinolones in Germany. Deutsches Ärzteblatt International, 2016. 113(26): p.454. PubMedPubMedCentral Bätzing-Feigenbaum, J., et al., Outpatient antibiotic prescription: a population-based study on regional age-related use of cephalosporins and fluoroquinolones in Germany. Deutsches Ärzteblatt International, 2016. 113(26): p.454. PubMedPubMedCentral
2.
Zurück zum Zitat Kolsin, J.M., et al., Evaluating Previous Antibiotic Use as a Risk Factor for Acute Gastroenteritis Among Children in Davidson County, Tennessee, 2014-2015. J Pediatric Infect Dis Soc, 2018. 7(3): p.e86–e91. PubMedCrossRef Kolsin, J.M., et al., Evaluating Previous Antibiotic Use as a Risk Factor for Acute Gastroenteritis Among Children in Davidson County, Tennessee, 2014-2015. J Pediatric Infect Dis Soc, 2018. 7(3): p.e86–e91. PubMedCrossRef
3.
Zurück zum Zitat DEGAM. S2k Leitlinie Rhinosinusitis. 2017. DEGAM. S2k Leitlinie Rhinosinusitis. 2017.
4.
Zurück zum Zitat Gottschlich, S., K. Roschmann, and H. Candler, Phytomedicines in Acute Rhinosinusitis: A Prospective, Non-interventional Parallel-Group Trial. Adv Ther, 2018. 35(7): p. 1023–1034. PubMedCrossRef Gottschlich, S., K. Roschmann, and H. Candler, Phytomedicines in Acute Rhinosinusitis: A Prospective, Non-interventional Parallel-Group Trial. Adv Ther, 2018. 35(7): p. 1023–1034. PubMedCrossRef
5.
Zurück zum Zitat Tesche, S., et al., The value of herbal medicines in the treatment of acute non-purulent rhinosinusitis. European Archives of Oto-Rhino-Laryngology, 2008. 265(11): p. 1355. PubMedCrossRef Tesche, S., et al., The value of herbal medicines in the treatment of acute non-purulent rhinosinusitis. European Archives of Oto-Rhino-Laryngology, 2008. 265(11): p. 1355. PubMedCrossRef
6.
Zurück zum Zitat Bachert, C., et al., Treatment of acute rhinosinusitis with the preparation from Pelargonium sidoides EPs 7630: a randomized, double-blind, placebo-controlled trial. Rhinology, 2009. 47(1): p. 51. PubMed Bachert, C., et al., Treatment of acute rhinosinusitis with the preparation from Pelargonium sidoides EPs 7630: a randomized, double-blind, placebo-controlled trial. Rhinology, 2009. 47(1): p. 51. PubMed
7.
Zurück zum Zitat Timmer, A., et al., Pelargonium sidoides extract for treating acute respiratory tract infections. Cochrane Database of Systematic Reviews, 2013(10). Timmer, A., et al., Pelargonium sidoides extract for treating acute respiratory tract infections. Cochrane Database of Systematic Reviews, 2013(10).
8.
Zurück zum Zitat Stewart, E.H., et al., Rapid antigen group A streptococcus test to diagnose pharyngitis: a systematic review and meta-analysis. PLoS One, 2014. 9(11): p. e111727. PubMedPubMedCentralCrossRef Stewart, E.H., et al., Rapid antigen group A streptococcus test to diagnose pharyngitis: a systematic review and meta-analysis. PLoS One, 2014. 9(11): p. e111727. PubMedPubMedCentralCrossRef
9.
Zurück zum Zitat DEGAM. Leitlinie Nr. 14: Halsschmerzen. 2009. DEGAM. Leitlinie Nr. 14: Halsschmerzen. 2009.
10.
Zurück zum Zitat Spinks, A., P.P. Glasziou, and C.B. Del Mar, Antibiotics for sore throat. Cochrane Database Syst Rev, 2013(11): p. Cd000023. Spinks, A., P.P. Glasziou, and C.B. Del Mar, Antibiotics for sore throat. Cochrane Database Syst Rev, 2013(11): p. Cd000023.
11.
Zurück zum Zitat Sadeghirad, B., et al., Corticosteroids for treatment of sore throat: systematic review and meta-analysis of randomised trials. bmj, 2017. 358: p. j3887. PubMedPubMedCentralCrossRef Sadeghirad, B., et al., Corticosteroids for treatment of sore throat: systematic review and meta-analysis of randomised trials. bmj, 2017. 358: p. j3887. PubMedPubMedCentralCrossRef
12.
Zurück zum Zitat DEGAM. Leitlinie Nr. 11: Husten. 2014. DEGAM. Leitlinie Nr. 11: Husten. 2014.
13.
Zurück zum Zitat Gillissen, A., et al., A multi-centre, randomised, double-blind, placebo-controlled clinical trial on the efficacy and tolerability of GeloMyrtol(R) forte in acute bronchitis. Drug Res (Stuttg), 2013. 63(1): p. 19–27. CrossRef Gillissen, A., et al., A multi-centre, randomised, double-blind, placebo-controlled clinical trial on the efficacy and tolerability of GeloMyrtol(R) forte in acute bronchitis. Drug Res (Stuttg), 2013. 63(1): p. 19–27. CrossRef
14.
Zurück zum Zitat Kemmerich, B., R. Eberhardt, and H. Stammer, Efficacy and tolerability of a fluid extract combination of thyme herb and ivy leaves and matched placebo in adults suffering from acute bronchitis with productive cough. A prospective, double-blind, placebo controlled clinical trial. Arzneimittelforschung, 2006. 56(9): p. 652–60. PubMed Kemmerich, B., R. Eberhardt, and H. Stammer, Efficacy and tolerability of a fluid extract combination of thyme herb and ivy leaves and matched placebo in adults suffering from acute bronchitis with productive cough. A prospective, double-blind, placebo controlled clinical trial. Arzneimittelforschung, 2006. 56(9): p. 652–60. PubMed
15.
Zurück zum Zitat Kemmerich, B., Evaluation of efficacy and tolerability of a fixed combination of dry extracts of thyme herb and primrose root in adults suffering from acute bronchitis with productive cough. A prospective, double-blind, placebo-controlled multicentre clinical trial. Arzneimittelforschung, 2007. 57(9): p. 607–15. PubMed Kemmerich, B., Evaluation of efficacy and tolerability of a fixed combination of dry extracts of thyme herb and primrose root in adults suffering from acute bronchitis with productive cough. A prospective, double-blind, placebo-controlled multicentre clinical trial. Arzneimittelforschung, 2007. 57(9): p. 607–15. PubMed
16.
Zurück zum Zitat Schaefer, A., et al., A randomized, controlled, double-blind, multi-center trial to evaluate the efficacy and safety of a liquid containing ivy leaves dry extract (EA 575((R))) vs. placebo in the treatment of adults with acute cough. Pharmazie, 2016. 71(9): p. 504–509. PubMed Schaefer, A., et al., A randomized, controlled, double-blind, multi-center trial to evaluate the efficacy and safety of a liquid containing ivy leaves dry extract (EA 575((R))) vs. placebo in the treatment of adults with acute cough. Pharmazie, 2016. 71(9): p. 504–509. PubMed
17.
Zurück zum Zitat Gonzales, R. and M.A. Sande, Uncomplicated acute bronchitis. Ann Intern Med, 2000. 133(12): p. 981–91. PubMedCrossRef Gonzales, R. and M.A. Sande, Uncomplicated acute bronchitis. Ann Intern Med, 2000. 133(12): p. 981–91. PubMedCrossRef
18.
Zurück zum Zitat Afshar K., H.M., Junius-Walker U., Schneider N., Krause O., Was tun Hausärzte und Medizinische Fachangestellte, wenn sie selbst erkältet sind? Z Allg Med, 2016. 92(9): p. 339–345. Afshar K., H.M., Junius-Walker U., Schneider N., Krause O., Was tun Hausärzte und Medizinische Fachangestellte, wenn sie selbst erkältet sind? Z Allg Med, 2016. 92(9): p. 339–345.
19.
Zurück zum Zitat Bautsch W., E.H., Fünfstück R., Hamm M., Lehners T., Naber K., Nau R., Olzowy B., Schierholz R, Sunderkötter C., Vonberg R., Wedemeyer J., Rationale orale Antibiotikatherapie für Erwachsene im niedergelassenen Bereich, N. Gesundheitsamt, Editor. 2018, Niedersächsisches Gesundheitsamt: Hannover. Bautsch W., E.H., Fünfstück R., Hamm M., Lehners T., Naber K., Nau R., Olzowy B., Schierholz R, Sunderkötter C., Vonberg R., Wedemeyer J., Rationale orale Antibiotikatherapie für Erwachsene im niedergelassenen Bereich, N. Gesundheitsamt, Editor. 2018, Niedersächsisches Gesundheitsamt: Hannover.
20.
Zurück zum Zitat Vogelmeier, C., et al., [Guideline for the Diagnosis and Treatment of COPD Patients - Issued by the German Respiratory Society and the German Atemwegsliga in Cooperation with the Austrian Society of Pneumology]. Pneumologie, 2018. 72(4): p. 253–308. PubMedCrossRef Vogelmeier, C., et al., [Guideline for the Diagnosis and Treatment of COPD Patients - Issued by the German Respiratory Society and the German Atemwegsliga in Cooperation with the Austrian Society of Pneumology]. Pneumologie, 2018. 72(4): p. 253–308. PubMedCrossRef
21.
Zurück zum Zitat Salm, F., et al., Antibiotic prescribing behavior among general practitioners-a questionnaire-based study in Germany. BMC infectious diseases, 2018. 18(1): p. 208. PubMedPubMedCentralCrossRef Salm, F., et al., Antibiotic prescribing behavior among general practitioners-a questionnaire-based study in Germany. BMC infectious diseases, 2018. 18(1): p. 208. PubMedPubMedCentralCrossRef
22.
Zurück zum Zitat Altiner, A., et al., Reducing antibiotic prescriptions for acute cough by motivating GPs to change their attitudes to communication and empowering patients: a cluster-randomized intervention study. Journal of Antimicrobial Chemotherapy, 2007. 60(3): p. 638–644. PubMedCrossRef Altiner, A., et al., Reducing antibiotic prescriptions for acute cough by motivating GPs to change their attitudes to communication and empowering patients: a cluster-randomized intervention study. Journal of Antimicrobial Chemotherapy, 2007. 60(3): p. 638–644. PubMedCrossRef
23.
Zurück zum Zitat Faber, M.S., et al., Antibiotics for the common cold: expectations of Germany's general population. Euro Surveill, 2010. 15(35). Faber, M.S., et al., Antibiotics for the common cold: expectations of Germany's general population. Euro Surveill, 2010. 15(35).
24.
Zurück zum Zitat Klingenberg A., B.T., Andres E., Kaufmann-Kolle P., Wambach V., Szescenyi J., Was wissen Patienten über Antibiotika, und wie häufig erwarten sie deren Verordnung? Z Allg Med, 2019. 95(5): p. 198–201. Klingenberg A., B.T., Andres E., Kaufmann-Kolle P., Wambach V., Szescenyi J., Was wissen Patienten über Antibiotika, und wie häufig erwarten sie deren Verordnung? Z Allg Med, 2019. 95(5): p. 198–201.
25.
Zurück zum Zitat Aabenhus, R., et al., Biomarkers as point-of-care tests to guide prescription of antibiotics in patients with acute respiratory infections in primary care. Cochrane Database Syst Rev, 2014(11): p. Cd010130. Aabenhus, R., et al., Biomarkers as point-of-care tests to guide prescription of antibiotics in patients with acute respiratory infections in primary care. Cochrane Database Syst Rev, 2014(11): p. Cd010130.
26.
Zurück zum Zitat Schuetz, P., et al., Procalcitonin-guided antibiotic therapy algorithms for different types of acute respiratory infections based on previous trials. Expert Rev Anti Infect Ther, 2018. 16(7): p. 555–564. PubMedCrossRef Schuetz, P., et al., Procalcitonin-guided antibiotic therapy algorithms for different types of acute respiratory infections based on previous trials. Expert Rev Anti Infect Ther, 2018. 16(7): p. 555–564. PubMedCrossRef
27.
Zurück zum Zitat Høye, S., S. Gjelstad, and M. Lindbæk, Effects on antibiotic dispensing rates of interventions to promote delayed prescribing for respiratory tract infections in primary care. Br J Gen Pract, 2013. 63(616): p. e777–e786. PubMedPubMedCentralCrossRef Høye, S., S. Gjelstad, and M. Lindbæk, Effects on antibiotic dispensing rates of interventions to promote delayed prescribing for respiratory tract infections in primary care. Br J Gen Pract, 2013. 63(616): p. e777–e786. PubMedPubMedCentralCrossRef
28.
Zurück zum Zitat Gong, C.L., et al., Behavioral Economics Interventions to Improve Outpatient Antibiotic Prescribing for Acute Respiratory Infections: a Cost-Effectiveness Analysis. J Gen Intern Med, 2019. 34(6): p. 846–854. PubMedCrossRef Gong, C.L., et al., Behavioral Economics Interventions to Improve Outpatient Antibiotic Prescribing for Acute Respiratory Infections: a Cost-Effectiveness Analysis. J Gen Intern Med, 2019. 34(6): p. 846–854. PubMedCrossRef
29.
Zurück zum Zitat Persell, S.D., et al., Behavioral interventions to reduce inappropriate antibiotic prescribing: a randomized pilot trial. BMC Infect Dis, 2016. 16: p. 373. PubMedPubMedCentralCrossRef Persell, S.D., et al., Behavioral interventions to reduce inappropriate antibiotic prescribing: a randomized pilot trial. BMC Infect Dis, 2016. 16: p. 373. PubMedPubMedCentralCrossRef
30.
Zurück zum Zitat Hallsworth, M., et al., Provision of social norm feedback to high prescribers of antibiotics in general practice: a pragmatic national randomised controlled trial. Lancet, 2016. 387(10029): p. 1743–52. PubMedPubMedCentralCrossRef Hallsworth, M., et al., Provision of social norm feedback to high prescribers of antibiotics in general practice: a pragmatic national randomised controlled trial. Lancet, 2016. 387(10029): p. 1743–52. PubMedPubMedCentralCrossRef
31.
Zurück zum Zitat Meeker, D., et al., Effect of Behavioral Interventions on Inappropriate Antibiotic Prescribing Among Primary Care Practices: A Randomized Clinical Trial. Jama, 2016. 315(6): p. 562–70. PubMedPubMedCentralCrossRef Meeker, D., et al., Effect of Behavioral Interventions on Inappropriate Antibiotic Prescribing Among Primary Care Practices: A Randomized Clinical Trial. Jama, 2016. 315(6): p. 562–70. PubMedPubMedCentralCrossRef
32.
Zurück zum Zitat Gulliford, M.C., et al., Effectiveness and safety of electronically delivered prescribing feedback and decision support on antibiotic use for respiratory illness in primary care: REDUCE cluster randomised trial. Bmj, 2019. 364: p. 1236. Gulliford, M.C., et al., Effectiveness and safety of electronically delivered prescribing feedback and decision support on antibiotic use for respiratory illness in primary care: REDUCE cluster randomised trial. Bmj, 2019. 364: p. 1236.
33.
Zurück zum Zitat Dyrkorn, R., et al., Peer academic detailing on use of antibiotics in acute respiratory tract infections. A controlled study in an urban Norwegian out-of-hours service. Scand J Prim Health Care, 2016. 34(2): p. 180–5. Dyrkorn, R., et al., Peer academic detailing on use of antibiotics in acute respiratory tract infections. A controlled study in an urban Norwegian out-of-hours service. Scand J Prim Health Care, 2016. 34(2): p. 180–5.
34.
Zurück zum Zitat Pittenger, K., et al., Improving acute respiratory infection care through nurse phone care and academic detailing of physicians. J Am Board Fam Med, 2015. 28(2): p. 195–204. PubMedCrossRef Pittenger, K., et al., Improving acute respiratory infection care through nurse phone care and academic detailing of physicians. J Am Board Fam Med, 2015. 28(2): p. 195–204. PubMedCrossRef
35.
Zurück zum Zitat Gulliford, M.C., et al., Safety of reduced antibiotic prescribing for self limiting respiratory tract infections in primary care: cohort study using electronic health records. bmj, 2016. 354: p. i3410. PubMedPubMedCentralCrossRef Gulliford, M.C., et al., Safety of reduced antibiotic prescribing for self limiting respiratory tract infections in primary care: cohort study using electronic health records. bmj, 2016. 354: p. i3410. PubMedPubMedCentralCrossRef
Metadaten
Titel
Infektionen der oberen Atemwege
verfasst von
MPH Dr. med. Inga Petruschke
Prof. Dr. Mathias W. Pletz
Prof. Dr. Jutta Bleidorn
Publikationsdatum
11.12.2019
Verlag
Springer Medizin
Erschienen in
CME / Ausgabe 12/2019
Print ISSN: 1614-371X
Elektronische ISSN: 1614-3744
DOI
https://doi.org/10.1007/s11298-019-7099-5